FDA Approves Ranbaxy’s Lipitor Generic – How Does the Agency Approve Generic Drugs?

• By: Staff Editor
• Date: December 12, 2011

In late November 2011, Ranbaxy won approval from the FDA to start selling its generic version of Pfizer’s cholesterol drug, Lipitor. The approval was given as Pfizer’s patent for the drug had expired.

This article explains how the FDA approves generic drugs and how Pfizer is trying to lessen the impact of the Lipitor patent expiry.